Business Description
QuiaPEG Pharmaceuticals Holding AB
ISIN : SE0020678159
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | -2.13 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 90.5 | |||||
3-Year EPS without NRI Growth Rate | 90.2 | |||||
3-Year FCF Growth Rate | 87.6 | |||||
3-Year Book Growth Rate | 48.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.84 | |||||
9-Day RSI | 36.32 | |||||
14-Day RSI | 41.5 | |||||
6-1 Month Momentum % | -57.69 | |||||
12-1 Month Momentum % | -29.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.33 | |||||
Days Sales Outstanding | 34.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -305.2 | |||||
Shareholder Yield % | -56.11 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 156.44 | |||||
Operating Margin % | -575 | |||||
Net Margin % | -587.29 | |||||
FCF Margin % | -1259.33 | |||||
ROE % | -70.92 | |||||
ROA % | -38.12 | |||||
ROIC % | -31.46 | |||||
ROC (Joel Greenblatt) % | -4334.82 | |||||
ROCE % | -57.89 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.7 | |||||
PB Ratio | 1.49 | |||||
EV-to-EBIT | -2.1 | |||||
EV-to-EBITDA | -2.97 | |||||
EV-to-Revenue | 12.09 | |||||
EV-to-FCF | -1.64 | |||||
Earnings Yield (Greenblatt) % | -47.52 | |||||
FCF Yield % | -94.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
QuiaPEG Pharmaceuticals Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.209 | ||
EPS (TTM) (€) | -0.003 | ||
Beta | 4.52 | ||
Volatility % | 162.37 | ||
14-Day RSI | 41.5 | ||
14-Day ATR (€) | 0.000384 | ||
20-Day SMA (€) | 0.002195 | ||
12-1 Month Momentum % | -29.03 | ||
52-Week Range (€) | 0.0001 - 0.0153 | ||
Shares Outstanding (Mil) | 1,489.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
QuiaPEG Pharmaceuticals Holding AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
QuiaPEG Pharmaceuticals Holding AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
QuiaPEG Pharmaceuticals Holding AB Frequently Asked Questions
What is QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)'s stock price today?
When is next earnings date of QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)?
Does QuiaPEG Pharmaceuticals Holding AB(FRA:99B0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |